Percutaneous Transcatheter Mitral Valve Replacement for Symptomatic Mitral Regurgitation
Authors:
- John WebbJWJohn Webb
- Mayra E. GuerreroMGMayra E. Guerrero
- Kamran I. MuhammadKMKamran I. Muhammad
- Adam B. GreenbaumAGAdam B. Greenbaum
- Alejandro VasquezAVAlejandro Vasquez
- J. Bradley OldemeyerJOJ. Bradley Oldemeyer
- Thom G. DahleTDThom G. Dahle
- Brian P. O’NEillBOBrian P. O’NEill
- Charanjit RihalCRCharanjit Rihal
- Michael MorseMMMichael Morse
- Evelio RodriguezEREvelio Rodriguez
- Mark RussoMRMark Russo
Abstract
No abstract availableFunding Information
- Edwards Lifesciences
This publication has 25 references indexed in Scilit:
- ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart DiseasesJACC, 2023
- Transcatheter Edge-to-Edge Repair in Patients With Anatomically Complex Degenerative Mitral RegurgitationJACC, 2023
- Characteristics and outcomes of patients screened for transcatheter mitral valve implantation: 1‐year results from the CHOICE‐MI registryEuropean Journal of Heart Failure, 2022
- 2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral RegurgitationJACC, 2021
- 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart FailureJACC, 2021
- Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation: Outcomes at 2 YearsEuropean Journal of Heart Failure, 2019
- Percutaneous Transcatheter Mitral Valve ReplacementJACC, 2019
- Survival and Cardiovascular Outcomes of Patients With Secondary Mitral RegurgitationJAMA Cardiology, 2017
- Secondary Mitral Regurgitation in Heart FailureJACC, 2015
- Analyzing survival curves at a fixed point in timeStatistics in Medicine, 2007